melanotan-ii has been researched along with corticosterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clegg, DJ; Drazen, DL; Schwartz, MW; Seeley, RJ; van Dijk, G; Woods, SC; Wortman, MD | 1 |
| Corssmit, EP; Havekes, LM; Heijboer, AC; Pijl, H; Romijn, JA; van den Hoek, AM; Voshol, PJ | 1 |
2 other study(ies) available for melanotan-ii and corticosterone
| Article | Year |
|---|---|
Adrenalectomy alters the sensitivity of the central nervous system melanocortin system.
Topics: Adrenalectomy; Agouti-Related Protein; alpha-MSH; Animals; Appetite; Central Nervous System; Corticosterone; Dose-Response Relationship, Drug; Eating; Glucocorticoids; Injections, Intraventricular; Intercellular Signaling Peptides and Proteins; Leptin; Male; Peptides, Cyclic; Proteins; Rats; Rats, Long-Evans; Receptor, Melanocortin, Type 4; Receptors, Melanocortin; Third Ventricle | 2003 |
Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice.
Topics: alpha-MSH; Animals; Blood Glucose; Corticosterone; Fatty Acids, Nonesterified; Glucose; Glucose Clamp Technique; Glucose Transporter Type 4; Injections, Intraventricular; Insulin; Insulin Resistance; Kinetics; Liver; Male; Mice; Mice, Inbred C57BL; Monosaccharide Transport Proteins; Muscle Proteins; Peptides, Cyclic; Receptor, Melanocortin, Type 3; Receptor, Melanocortin, Type 4; RNA, Messenger | 2005 |